Pharmaceutical

Pfizer touts positive topline data for RSV vaccine Abrysvo

Abrysvo was found to be safe in immunocompromised adults at risk for developing RSV-associated lower respiratory tract disease.

Aug 13, 2024 - 04:00
Pfizer touts positive topline data for RSV vaccine Abrysvo
Abrysvo was found to be safe in immunocompromised adults at risk for developing RSV-associated lower respiratory tract disease.
Read the original article

Tags:

Previous Article

FDA approves Sandoz’s Enzeevu as Eylea biosimilar saga continues

Next Article

Patient with rare neurodegenerative disorder improves with non-profit’s ASO therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Alternative therapies are needed to combat the impending threat of AMR

Alternative therapies are needed to combat the impendin...

Feb 6, 2024

STAT+: Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty med costs

STAT+: Pharmalittle: FDA panel backs conditional approv...

Mar 24, 2023

In the whitewashed world of Alzheimer’s research, one scientist is on a quest to understand the diversity of brains

In the whitewashed world of Alzheimer’s research, one s...

Mar 30, 2023